The clinical potential of ex vivo lung perfusion

被引:1
|
作者
Cypel, Marcelo [1 ]
Keshavjee, Shaf [1 ]
机构
[1] Univ Toronto, Toronto, ON M5S 1A1, Canada
关键词
ex vivo lung perfusion; lung injury; lung preservation; lung repair; regeneration; ISCHEMIA-REPERFUSION INJURY; ISHLT WORKING GROUP; DONOR LUNGS; CARDIAC DEATH; GRAFT DYSFUNCTION; HUMAN INTERLEUKIN-10; PULMONARY-EMBOLISM; GENE-TRANSFER; TRANSPLANTATION; HEART;
D O I
10.1586/ERS.11.93
中图分类号
R56 [呼吸系及胸部疾病];
学科分类号
摘要
Expert Rev. Respir. Med. 6(1), 27-35 (2012) The number of patients listed for lung transplantation largely exceeds the number of available transplantable organs because of both a shortage of organ donors and a low utilization rate of donor lungs. Normothermic ex vivo lung perfusion (EVLP) is a method that maintains the organ in physiologically protective conditions outside the body during preservation, and shows great promise to increase utilization of donor lungs by allowing more accurate evaluation, as well as treatment and repair, of damaged donor lungs prior to transplantation. This article will cover the rationale, technical details and results of experimental and clinical studies with EVLP. The significant potential applications of EVLP in lung transplantation, lung regeneration and oncology are discussed.
引用
收藏
页码:27 / 35
页数:9
相关论文
共 50 条
  • [1] Current status and future potential of ex vivo lung perfusion in clinical lung transplantation
    Zhou, Alice L. L.
    Larson, Emily L. L.
    Ruck, Jessica M. M.
    Ha, Jinny S. S.
    Casillan, Alfred J. J.
    Bush, Errol L. L.
    [J]. ARTIFICIAL ORGANS, 2023, 47 (11) : 1700 - 1709
  • [2] The evolving potential for pediatric ex vivo lung perfusion
    Luc, Jessica G. Y.
    Nagendran, Jayan
    [J]. PEDIATRIC TRANSPLANTATION, 2016, 20 (01) : 13 - 22
  • [3] Normothermic Ex Vivo Lung Perfusion in Clinical Lung Transplantation
    Yeung J.C.
    Keshavjee S.
    [J]. Current Transplantation Reports, 2015, 2 (4) : 324 - 328
  • [4] Normothermic Ex Vivo Lung Perfusion in Clinical Lung Transplantation
    Cypel, Marcelo
    Yeung, Jonathan C.
    Liu, Mingyao
    Anraku, Masaki
    Chen, Fengshi
    Karolak, Wojtek
    Sato, Masaaki
    Laratta, Jane
    Azad, Sassan
    Madonik, Mindy
    Chow, Chung-Wai
    Chaparro, Cecilia
    Hutcheon, Michael
    Singer, Lianne G.
    Slutsky, Arthur S.
    Yasufuku, Kazuhiro
    de Perrot, Marc
    Pierre, Andrew F.
    Waddell, Thomas K.
    Keshavjee, Shaf
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2011, 364 (15): : 1431 - 1440
  • [5] Clinical Ex Vivo Lung Perfusion Pushing the Limits
    Aigner, C.
    Slama, A.
    Hoetzenecker, K.
    Urbanek, B.
    Schmid, W.
    Scheed, A.
    Lang, G.
    Keshavjee, S.
    Klepetko, W.
    [J]. JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2011, 30 (04): : S38 - S38
  • [6] International Clinical Experiences with Ex Vivo Lung Perfusion
    Sanchez, Pablo G.
    Griffith, Bartley P.
    [J]. CURRENT SURGERY REPORTS, 2014, 2 (03):
  • [7] Clinical Ex Vivo Lung Perfusion - Pushing the Limits
    Aigner, C.
    Slama, A.
    Hoetzenecker, K.
    Scheed, A.
    Urbanek, B.
    Schmid, W.
    Nierscher, F. J.
    Lang, G.
    Klepetko, W.
    [J]. AMERICAN JOURNAL OF TRANSPLANTATION, 2012, 12 (07) : 1839 - 1847
  • [8] International Clinical Experiences with Ex Vivo Lung Perfusion
    Pablo G. Sanchez
    Bartley P. Griffith
    [J]. Current Surgery Reports, 2 (3)
  • [9] Ex vivo lung perfusion
    Rajab, Taufiek Konrad
    Keshavjee, Shaf
    [J]. ARTIFICIAL ORGANS, 2020, 44 (01) : 12 - 15
  • [10] Ex vivo lung perfusion
    Reeb, Jeremie
    Cypel, Marcelo
    [J]. CLINICAL TRANSPLANTATION, 2016, 30 (03) : 183 - 194